{"date":"2026-01-16","count":9,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4745-2026-01-16-1923-1f9ldtp","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-01-16","time":"19:23:27","subject":"公告本公司114年12月份自結應收帳款餘額及回收情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-01-16 19:23，「公告本公司114年12月份自結應收帳款餘額及回收情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7427-2026-01-16-1833-p67uuk","company_id":"7427","company":"華上生醫","market":"興櫃","industry":"生技醫療","date":"2026-01-16","time":"18:33:46","subject":"公告本公司內部稽核主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華上生醫（7427），2026-01-16 18:33，「公告本公司內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7427-2026-01-16-1832-1vjqj49","company_id":"7427","company":"華上生醫","market":"興櫃","industry":"生技醫療","date":"2026-01-16","time":"18:32:19","subject":"公告本公司財務主管、會計主管及代理發言人異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華上生醫（7427），2026-01-16 18:32，「公告本公司財務主管、會計主管及代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6461-2026-01-16-1721-sqgrt0","company_id":"6461","company":"益得","market":"上櫃","industry":"生技醫療","date":"2026-01-16","time":"17:21:29","subject":"公告本公司法人董事代表人異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益得（6461），2026-01-16 17:21，「公告本公司法人董事代表人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4173-2026-01-16-1713-1vhu1xi","company_id":"4173","company":"久裕","market":"上櫃","industry":"生技醫療","date":"2026-01-16","time":"17:13:17","subject":"公告本公司發言人異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：久裕（4173），2026-01-16 17:13，「公告本公司發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4173-2026-01-16-1709-wr0tu2","company_id":"4173","company":"久裕","market":"上櫃","industry":"生技醫療","date":"2026-01-16","time":"17:09:42","subject":"公告本公司總經理異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：久裕（4173），2026-01-16 17:09，「公告本公司總經理異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7713-2026-01-16-1612-1su03io","company_id":"7713","company":"威力德生醫","market":"上櫃","industry":"生技醫療","date":"2026-01-16","time":"16:12:03","subject":"公告本公司執行長異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：威力德生醫（7713），2026-01-16 16:12，「公告本公司執行長異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4105-2026-01-16-1544-1x6bqhp","company_id":"4105","company":"東洋","market":"上櫃","industry":"生技醫療","date":"2026-01-16","time":"15:44:29","subject":"公告本公司114年12月份自結合併損益","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：東洋（4105），2026-01-16 15:44，「公告本公司114年12月份自結合併損益」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4162-2026-01-16-1500-1e6c9jj","company_id":"4162","company":"智擎","market":"上櫃","industry":"生技醫療","date":"2026-01-16","time":"15:00:35","subject":"智擎公司公告將獲得再授權收入美金150萬元","clause":"第53款","fact_date":"2026-01-16","cite_as":"公開資訊觀測站重大訊息：智擎（4162），2026-01-16 15:00，「智擎公司公告將獲得再授權收入美金150萬元」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}